Daniel C Maneval - Canji, Inc. San Diego

基本信息

Career Trajectory

Bio

Development-oriented scientific leader with extensive experience in small/emerging biotechnology companies as well as large biopharmaceutical organizations. Expertise in oncology, gene therapy, drug delivery and pharmacokinetics with contributions to all stages of drug development from IND (e.g., Herceptin®, Adstiladrin® gene therapy) through BLA and US/EU approval (e.g., HYQVIA™, HYLECTA™).

Research Interests

Papers共 131 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

The Safety of Recombinant Human Hyaluronidase PH20 in Nonclinical Models: an Overview of Toxicology, Pharmacology, and Impact of Anti-Ph20 Antibodies

Ryan P. Nolan,David W. Kang,Daniel C. Maneval, Stephen P. Knowles,Michael J. LaBarre,Marie A. Printz

JOURNAL OF CONTROLLED RELEASE（2024）

Cited0Views0WOSBibtex

Characterization and Pharmacokinetics of Ligand Traps Targeting the Human Epidermal Growth Factor Receptor (HER) Family

Daniel C. Maneval,Cindy Yang, Cynthia Trevisiol,H. Michael Shepard,Pei Jin

CANCER RESEARCHno. 6 (2024)

Cited0Views0Bibtex

Figure S4 from Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression

Xiaoming Li,H. Michael Shepard,Jessica A. Cowell, Chunmei Zhao,Ryan J. Osgood,Sanna Rosengren,Barbara Blouw,Sheryl A. Garrovillo,Mark D. Pagel,Clifford J. Whatcott,Haiyong Han,Daniel D. Von Hoff,Darin M. Taverna,Michael J. LaBarre,Daniel C. Maneval,Curtis B. Thompson

openalex（2023）

Cited0Views0Bibtex

Figure S1 from Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression

openalex（2023）

Cited0Views0Bibtex

JNTX-101, a Novel Albumin-Encapsulated Gemcitabine Prodrug, is Efficacious and Operates Via Caveolin-1-mediated Endocytosis

Tiantian Cui,Sergio Corrales-Guerrero,Veronica Castro-Aceituno,Sindhu Nair,Daniel C. Maneval,Curtis Monnig,Patrick Kearney,Sam Ellis, Nicholas Raheja, Neil Raheja,Terence M. Williams

MOLECULAR THERAPY-ONCOLYTICS（2023）

Cited3Views0WOSBibtex

Figure S2 from Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression

Xiaoming Li,H. Michael Shepard,Jessica A. Cowell,Chunmei Zhao,Ryan J. Osgood,Sanna Rosengren,Barbara Blouw,Sheryl A. Garrovillo,Mark D. Pagel,Clifford J. Whatcott,Haiyong Han,Daniel D. Von Hoff,Darin M. Taverna,Michael J. LaBarre,Daniel C. Maneval,Curtis B. Thompson

openalex（2023）

Cited0Views0Bibtex

Figure S3 from Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression

openalex（2023）

Cited0Views0Bibtex

Risk Factors, Hyaluronidase Expression, and Clinical Immunogenicity of Recombinant Human Hyaluronidase PH20, an Enzyme Enabling Subcutaneous Drug Administration

Marie A. Printz,Barry J. Sugarman,Rudolph D. Paladini,Michael C. Jorge, Yan Wang,David W. Kang,Daniel C. Maneval,Michael J. LaBarre

The AAPS Journal（2022）

Cited6Views0WOSBibtex

Safety and Pharmacokinetics of Docetaxel in Combination with Pegvorhyaluronidase Alfa in Patients with Non‐small Cell Lung Cancer

Thomas Heineman,Megan Baumgart,Charvi Nanavati,Nash Gabrail,Scott A. Van Wart,Donald E. Mager,Daniel C. Maneval,Anas M. Fathallah,Rose E. Sekulovich

Clinical and Translational Science（2021）

Cited6Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn